Sophia Zoungas
 |
Sophia Zoungas | |
|---|---|
| Awards | Fellow of the Australian Academy of Health and Medical Sciences (2022) Keillon Award (2022) |
| Scientific career | |
| Fields | Diabetes |
| Institutions | Monash University Alfred Health |
| Thesis | Cardiovascular risk in chronic renal failure : impact of transplantation and folic acid therapy on outcome, artery structure and function (2006) |
Sophia Zoungas FAHMS is a clinical endocrinologist from Victoria, Australia. She is recognised for her work in the management of diabetes and its vascular complications and leads Australia's largest translational research program in diabetes care and benchmarking of diabetes services.[1] Zoungas's research explores the link between diabetes, glucose levels and cardiovascular risks and has enabled people with diabetes to be prescribed medication that reduce their cardiovascular risk factors.[1] She is head of the School of Public Health and Preventative Medicine at Monash University and is the Professor of Diabetes, Vascular Health and Ageing[2] and is also deputy director of Research at Alfred Health.[3]
In 2022 Zoungas was elected as a fellow of the Australian Academy of Health and Medical Sciences[1] and in the same year was awarded the Kellion Award from the Australian Diabetes Society.[4]
References[edit]
- ^ a b c "Professor Sophia Zoungas - AAHMS". aahms.org. 14 October 2022. Retrieved 3 November 2022.
- ^ "Sophia Zoungas". Monash University. Retrieved 3 November 2022.
- ^ "Prof Sophia Zoungas". Alfred Health. Retrieved 3 November 2022.
- ^ "Australian Diabetes Society - Past Award Recipients". diabetessociety.com.au. Retrieved 3 November 2022.
| Academics | |
|---|---|
| People | |
.svg){kind=small}   | This article about an Australian scientist is a stub. You can help Wikipedia by expanding it. |